Minnesota House aims to hit drug companies for opioid crisis

The Minnesota House voted to hold drug manufacturers responsible for the state's growing costs for dealing with the opioid crisis.The bill passed 94-34 after around four hours of debate that split mostly along party lines. It would support a wide range of prevention, education, intervention, treatment and recovery strategies. The state would pay for them by sharply raising its currently low annual registration fees for pharmaceutical manufacturers and drug wholesalers that sell or distribute opioids in Minnesota.